Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

McMaster University

$168,300.00

Reducing morbidity in critically ill children by re-evaluating the prophylaxis of stress ulcer-related upper gastrointestinal bleeding: A pilot randomized controlled trial.

FY 2017-18

Summary
Reducing the adverse effects experienced by critically ill children is an urgent research priority. Acute and severe illness can cause stress ulcers in the stomach. These ulcers can cause severe bleeding. Thus it makes sense trying to prevent stress ulcers, which can be done with drugs that decrease stomach acid. Despite little testing in children, more than half of critically ill children receive these medications. These may increase the risk of infections, which may be more common than bleeding itself. A large study is needed to test if withholding these medications reduces the risk of side effects and adverse events without increasing the risk of bleeding. Such trials in pediatric critical care are exceptionally challenging to complete. We are conducting a pilot randomized controlled trial in 6 Canadian Pediatric Intensive Care Units (PICUs) to test and refine the study procedures and see if a large trial is feasible to do. Children receiving life support in a PICU can participate. They will be given either a commonly used medication (pantoprazole) to reduce their stomach acid levels or an inactive placebo while they are in the PICU. We measure important aspects of successfully completing a trial: how many children we can recruit at each PICU, how quickly we can start the study medication, adherence to study protocol, and how often the study medication is given according to our protocol. This pilot trial is a critical part of a research program needed to ensure that a large trial is successful. The large trial will tell us if giving prophylaxis or withholding it is the preferred strategy. Either outcome will allow clinicians to reduce the burden of morbidity in all mechanically ventilated children balancing the risks and benefits of prophylaxis. This pilot trial will be critical to successfully completing such a challenging trial.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
370241
Name
Duffett Mark C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Randomized Controlled Trials 2
Projecttitle
Reducing morbidity in critically ill children by re-evaluating the prophylaxis of stress ulcer-related upper gastrointestinal bleeding: A pilot randomized controlled trial.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$168,300
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Clostridium Difficle Infection; Gastrointestinal Bleeding; Pediatric Critical Care; Pilot Trial; Proton-Pump Inhibitor; Randomized Controlled Trial; Stress Ulcer Prophylaxis; Ventilator-Associated Pneumonia
Abstract
Reducing the adverse effects experienced by critically ill children is an urgent research priority. Acute and severe illness can cause stress ulcers in the stomach. These ulcers can cause severe bleeding. Thus it makes sense trying to prevent stress ulcers, which can be done with drugs that decrease stomach acid. Despite little testing in children, more than half of critically ill children receive these medications. These may increase the risk of infections, which may be more common than bleeding itself. A large study is needed to test if withholding these medications reduces the risk of side effects and adverse events without increasing the risk of bleeding. Such trials in pediatric critical care are exceptionally challenging to complete. We are conducting a pilot randomized controlled trial in 6 Canadian Pediatric Intensive Care Units (PICUs) to test and refine the study procedures and see if a large trial is feasible to do. Children receiving life support in a PICU can participate. They will be given either a commonly used medication (pantoprazole) to reduce their stomach acid levels or an inactive placebo while they are in the PICU. We measure important aspects of successfully completing a trial: how many children we can recruit at each PICU, how quickly we can start the study medication, adherence to study protocol, and how often the study medication is given according to our protocol. This pilot trial is a critical part of a research program needed to ensure that a large trial is successful. The large trial will tell us if giving prophylaxis or withholding it is the preferred strategy. Either outcome will allow clinicians to reduce the burden of morbidity in all mechanically ventilated children balancing the risks and benefits of prophylaxis. This pilot trial will be critical to successfully completing such a challenging trial.
Competitiondate
201709
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Duffett, Mark C
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $168,300~ $0~